The Dermatology Digest

FEBRUARY 5, 2024

We are honored to be recognized for the 2024 People’s Choice Award by Octane’s esteemed judges, entrepreneurs and experts in dermatology and plastic surgery,” says Dina El-Sherif, MBA, founder and CEO of Trufacial, in a news release (Pictured above).

Dermatology 36

Dermatology Pharmaceutical Technology Sales 36

The Dermatology Digest

FEBRUARY 27, 2024

While both low-concentration and high-concentration strength biosimilars of Humira are marketed in the U.S. We strongly believe that biosimilars are important in addressing inflationary pressures in the healthcare system across all markets, especially in the U.S. Both Alvotech and Teva expect to launch SIMLANDI in the U.S.

Safety 36

Safety Marketing Pharmaceutical Partnerships 36

The Dermatology Digest

JULY 10, 2024

Almirall has licensed the rights to develop and commercialize lebrikizumab for the treatment of dermatology indications, including AD, in Europe. Almirall expects regulatory decisions for lebrikizumab in moderate-to-severe AD in additional European markets, including the United Kingdom and Switzerland in 2024.

Dermatitis 36

Dermatitis Safety Dermatology Marketing 36

The Dermatology Digest

AUGUST 13, 2024

The phase III OLYMPIA 1 and OLYMPIA 2 clinical trials evaluated the efficacy and safety of nemolizumab administered subcutaneously every four weeks in more than 500 patients with prurigo nodularis. Nemolizumab was generally well tolerated, and its safety profile was consistent with the phase II trial, and between the OLYMPIA 1 and 2 trials.

Dermatitis 36

Dermatitis Safety Clinic Dermatology 36

The Dermatology Digest

MARCH 22, 2024

1,2 Benzene has become a more recent focus of attention related to safety concerns, with an increase in independent product testing and also updated regulations by the Food and Drug Administration related to benzene. Public safety is the first priority of the AARS. Right now, there are many questions about this issue.

Rosacea 64

Rosacea Document Safety Ingredients 64

The Dermatology Digest

FEBRUARY 26, 2024

Swierk noted that the research on the safety implications of tattoos is still out. Regulation of tattoo inks on the American market is very recent. The tattoo inks available in the American and European markets differ because the latter is subject to stricter regulations, overseen by the European Chemicals Agency.

Ingredients 74

Ingredients Marketing Safety Dermatology 74

Renee Rouleau

MARCH 10, 2023

Learn more about the different marketing terms used in skin care and what they really mean. People tend to assume natural fragrances are better than synthetic ones, but I think a lot of this has to do with the increased popularity of “clean” beauty marketing. What is Fragrance? The short answer is no.

Skincare 195

Skincare Irritation Ingredients Sensitive Skin 195

The Dermatology Digest

MARCH 11, 2024

In addition, the European Medicines Agency has also accepted the Marketing Authorization Applications for nemolizumab in prurigo nodularis and atopic dermatitis. No new safety signals were observed in this trial. The FDA has granted nemolizumab Priority Review for prurigo nodularis.

Dermatitis 36

Dermatitis Safety Dermatology Eczema 36

The Dermatology Digest

JUNE 10, 2024

Marketing Authorization Application. Two global, randomized, double blind, placebo-controlled trials are planned (IZAR-1 and IZAR-2) to evaluate the efficacy and safety of the nanobody sonelokimab over one year.

Office 36

Office Safety Marketing Dermatology 36

The Beauty Brains

MAY 13, 2019

The Beauty Brains episode 182 – we cover beauty questions about BB glow facials The safety of self tanners Doing you own research and Hard water and your beauty products Beauty Science News Butt Masks Is natural deodorant necessary ? So, with the uncertain safety profile and the limited benefit I’m not sure I can recommend doing this.

Safety 40

Safety Facials Injections Ingredients 40

The Dermatology Digest

DECEMBER 15, 2023

The approval is based on data from the Phase 3 ECZTRA 6 trial, which evaluated the efficacy and safety of Adbry in 289 pediatric patients aged 12-17 years with moderate-to-severe AD who were candidates for systemic therapy. Chair, Department of Dermatology, Feinberg School of Medicine, Northwestern University in Chicago, in a news release.

Eczema 36

Eczema Dermatitis Safety Therapy 36

The Dermatology Digest

DECEMBER 15, 2023

The approval is based on data from the Phase 3 ECZTRA 6 trial, which evaluated the efficacy and safety of Adbry in 289 pediatric patients aged 12-17 years with moderate-to-severe AD who were candidates for systemic therapy. Chair, Department of Dermatology, Feinberg School of Medicine, Northwestern University in Chicago, in a news release.

Eczema 36

Eczema Dermatitis Safety Therapy 36

The Dermatology Digest

FEBRUARY 13, 2024

MediWound Ltd’s EscharEx bested market leader collagenase Santyl ointment in wound debridement, promotion of granulation tissue, and time to wound closure in patients with chronic venous leg ulcers (VLU). The safety profile and overall incidence of adverse wound reactions were comparable between arms. days for EscharEx vs. 76.0

Safety 36

Safety Marketing Office Clinic 36

The Dermatology Digest

MARCH 20, 2024

Starting at this year’s Miami Open, La Roche-Posay will have a Sun Safety Booth located on the Tennis Oasis, two additional sampling kiosks at key entry points, while also providing sunscreen to players and staff on the grounds. The Miami Open is taking place from March 17 to March 31 at Hard Rock Stadium in Miami Gardens, Florida.

Branding 36

Branding Partnerships Safety Dermatology 36

West Lake Dermatology

JANUARY 30, 2024

The market has seen a surge in at-home laser hair removal devices offering users the convenience of performing the treatment in the comfort of their homes. Safety should always be a top priority when considering any form of laser treatment. Professional laser hair removal achieves 95%+ hair removal within 7-9 sessions.

Hair Removal 36

Hair Removal Safety Technology Waxing 36

Art of Dermatology

MAY 17, 2024

At Art of Dermatology at the Laser and Skin Surgery Center of New York, patient safety and satisfaction is Dr. Jessica Krant’s primary concern. Remember, your health and safety are worth every penny spent on genuine Botox treatments. Counterfeit Botox is not merely ineffective; it’s potentially life-threatening as well.

Office 36

Office Surgery Safety Injections 36

The Dermatology Digest

JANUARY 4, 2024

The clinical results demonstrated that DMB-3115 and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of quality, safety and efficacy. market during the next five years. Accord BioPharma is planning to introduce several additional biosimilars to the U.S.

Pharmaceutical 36

Pharmaceutical Partnerships Clinic Safety 36

The Dermatology Digest

DECEMBER 15, 2023

The approval is based on data from the Phase 3 ECZTRA 6 trial, which evaluated the efficacy and safety of Adbry in 289 pediatric patients aged 12-17 years with moderate-to-severe AD who were candidates for systemic therapy. Chair, Department of Dermatology, Feinberg School of Medicine, Northwestern University in Chicago, in a news release.

Eczema 28

Eczema Dermatitis Safety Therapy 28

The Dermatology Digest

MARCH 6, 2024

Benzoyl Peroxide-based acne medications can become unstable and form benzene, a known human carcinogen, according to new research from Valisure, an independent laboratory focused on testing the purity and safety of pharmaceutical drugs and consumer products. Food and Drug Administration (FDA).

Sanitation 36

Sanitation Pharmaceutical Marketing Safety 36

US Dermatologt Partners

AUGUST 5, 2024

Dermatology Partners Denver, “Establishing good sun protection habits early has a lasting impact on a young person’s skin health. In this blog, Dr. Theriault provides top sunscreen and sun safety tips for kids and teens. Dermatology Partners by completing our online scheduling request form. Dermatology Partners.

Sun Protection 36

Sun Protection Skincare Routine Skin Health Safety 36

Southeastern Esthetics Institute

AUGUST 23, 2016

Having a thorough understanding of the dermatology and plastic surgery procedures, in addition to all new and modern cosmetic procedures on the market, is critical in assisting your clients in answering questions. Having daily and weekly communication when dealing with patients receiving treatment is critical.

Esthetician 195

Esthetician Esthetics Document Office 195

Aesthetic Advancements Institute (AAI)

JUNE 20, 2023

There is a new dermal filler on the market! Juvéderm’s® newest filler, Volux , has been approved by the FDA and is set to hit medical offices in early 2023. This new filler is designed to specifically target the jawline, an area of concern for many consumers seeking facial sculpting and contouring.

Training 36

Training Injections Medical Facials 36

Eminence Organics

OCTOBER 31, 2023

These days, there are a lot of facial steamers on the market, but you can also DIY at home with a big bowl or sink of warm water and a towel. Robinson says: “Heat and steam are known triggers for many dermatologic conditions, such as rosacea, melasma and eczema.” Visit your nearest Eminence Organics Spa Partner to find out more.

Facials 73

Facials Sebum Hydration Moisturization 73

The Dermatology Digest

AUGUST 30, 2023

Ted Lain, MD, MBA, board-certified dermatologist and Chief Medical Officer, Sanova Dermatology, Austin, Texas. But maybe it just takes some time for that to mature in the market.” IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines. J Drugs Dermatol.

Wrinkles 36

Wrinkles Office Safety Clinic 36

Eminence Organics

OCTOBER 31, 2023

These days, there are a lot of facial steamers on the market, but you can also DIY at home with a big bowl or sink of warm water and a towel. Robinson says: “Heat and steam are known triggers for many dermatologic conditions, such as rosacea, melasma and eczema.” Visit your nearest Eminence Organics Spa Partner to find out more.

Facials 70

Facials Sebum Hydration Moisturization 70

The Dermatology Digest

JULY 24, 2024

The two companies will collaborate in sales, marketing, education, and research. market share within three years. market,” says Ethan Min, CEO of BENEV, in a news release. .” market,” says Ethan Min, CEO of BENEV, in a news release. “We Hugel Inc.’s s botulinum toxin product Letybo is coming to the U.S.

Dermatology 78

Dermatology Sales Marketing Safety 78

The Dermatology Digest

APRIL 23, 2021

DAXI will get an approval, most likely, for the longest acting toxin that we’ve had on the market.” In anticipation of this longer lasting duration, other brands are clinically testing higher doses for safety, efficacy, and patient satisfaction.

Injections 36

Injections Safety Clinic Branding 36

First Derm

AUGUST 25, 2023

However, it is important to address the misconception that “natural” automatically equates to safety. By addressing the misconception surrounding the safety of natural skin care products, we can better understand the need for careful evaluation and consideration when choosing these products.

Dermatitis 40

Dermatitis Irritation Skincare Sensitive Skin 40

The Dermatology Digest

APRIL 23, 2024

The CRL did not identify any deficiencies related to the clinical efficacy or clinical safety data in the BLA, and the FDA did not request any new clinical trials or clinical data to support the approval of pz-cel. The BLA for pz-cel was accepted for filing and granted priority review designation by the FDA in November 2023.

Marketing 36

Marketing Safety Clinic Sustainability 36

The Dermatology Digest

APRIL 16, 2024

Market Access at Teva, in a news release. Bringing Selarsdi to market in the U.S. The post FDA Green Lights New Stelara Biosimilar appeared first on The Dermatology Digest. says Thomas Rainey, Senior Vice President, U.S. Robert Wessman, Chairman and CEO of Alvotech, adds, “.

Partnerships 74

Partnerships Injections Safety Marketing 74

The Dermatology Digest

FEBRUARY 26, 2024

Marketing Authorization Application. About the MIRA trial The MIRA trial (M1095-HS-201) is a global, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of the Nanobody sonelokimab, administered subcutaneously, in the treatment of adult patients with active moderate-to-severe hidradenitis suppurativa.

Office 74

Office Safety Innovations Clinic 74

The Dermatology Digest

MAY 23, 2024

Kimball, MD, MPH, Beth Israel Deaconess Medical Center and Professor of Dermatology, Harvard Medical School, Boston, MA. “In The safety profile of bimekizumab was consistent with safety data seen in previous trials with no new observed safety signals. The primary endpoint in both trials was HiSCR50 at Week 16.

Sustainability 36

Sustainability Safety Clinic Dermatology 36

Art of Dermatology

SEPTEMBER 6, 2023

Everyone from hotels to oil companies has participated in greenwashed marketing. When fraudulent, deceptive, or even just exaggerated environmental, health, and safety claims are made in the marketing of a product, that’s greenwashing. What is Greenwashing? Greenwashing is not a new tactic.

Branding 36

Branding Skincare Brands Skincare Ingredients 36

The Dermatology Digest

MAY 15, 2024

alone and no FDA approved therapies, common warts represent one of the largest unmet needs in all of dermatology. seeking Food and Drug Administration approval for the use of YCANTH for the treatment of common warts, but may also be utilized by Verrica to seek future marketing authorizations in territories outside the U.S.

Pharmaceutical 36

Pharmaceutical Clinic Sales Dermatology 36

The Dermatology Digest

FEBRUARY 9, 2024

There are systemic treatments on the market that have data for atopic dermatitis (AD) on the hands, but chronic hand eczema is defined as hand eczema that lasts for more than three months or relapses twice or more within a year – which applies to several other different kinds of hand eczema as well, not just AD.

Eczema 36

Eczema Dermatitis Marketing Safety 36

The Dermatology Digest

JULY 27, 2023

Patricia Farris, MD, Board-Certified Dermatologist, Sanova Dermatology, Metairie, La. So we just don’t have the standardization of what is being eliminated and no consensus as to what should be eliminated based on safety studies. We have lots of experience and long-term safety with petrolatum.

Sustainability 36

Sustainability Skincare Safety Ingredients 36

Aesthetics Advisor

AUGUST 7, 2023

As one doctor said, "we haven't seen a prescription drug with this much cocktail and dinner chatter since Viagra came to the market." Vitamin D A 2011 study in The Journal of Investigative Dermatology revealed a remarkable fact of metabolism: The exposure of human skin to UV light results in increased subcutaneous fat metabolism.

Diet 36

Diet Extractions Medical Sustainability 36